Evidence map›Paper›PMID 26284077›Full record

ReviewFrontiers in immunology2015

Regulatory T-Cell Development in the Human Thymus.

Íris Caramalho, Helena Nunes-Cabaço, Russell B Foxall, Ana E Sousa

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Anti-acetylcholine receptor antibody overshoot following efgartigimod in myasthenia gravis: Two case reports with literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. The Function of Ubiquitination in T-Cell Development.Advances in experimental medicine and biology · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Overexpression of Potential Markers of Regulatory and Exhausted CD8International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Íris CaramalhoInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Lisbon , Portugal.
Helena Nunes-CabaçoInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Lisbon , Portugal.
Russell B FoxallInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Lisbon , Portugal.
Ana E SousaInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Lisbon , Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The thymus generates a lineage-committed subset of regulatory T-cells (Tregs), best identified by the expression of the transcription factor FOXP3. The development of thymus-derived Tregs is known to require high-avidity interaction with MHC-self peptides leading to the generation of self-reactive Tregs fundamental for the maintenance of self-tolerance. Notwithstanding their crucial role in the control of immune responses, human thymic Treg differentiation remains poorly understood. In this mini-review, we will focus on the developmental stages at which Treg lineage commitment occurs, and their spatial localization in the human thymus, reviewing the molecular requirements, including T-cell receptor and cytokine signaling, as well as the cellular interactions involved. An overview of the impact of described thymic defects on the Treg compartment will be provided, illustrating the importance of these in vivo models to investigate human Treg development.

Indexed as

FOXP3human thymic defectshuman thymusprimary immunodeficiencyregulatory T-cell developmentregulatory T-cells

Identifiers

PMID26284077
PMCPMC4522873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.